Varicella zoster in children attending day care centers

Clinics

Volumn 61, Issue 2, 2006, Pages 147-152

  Marcitelli, Ricardo ^a   Bricks, Lucia Ferro ^a  

^a NONE

Author keywords

Children; Day care centers; Nonsteroidal antiinflammatory drugs; Varicella zoster complications

Indexed keywords

EID: 33646424757     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322006000200010     Document Type: Article

References (32)

1. th ed. Elk Groove Village; 2003.
2. Gershon AA, Takahashi M, Seward J. Varicella vaccine. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 4 ed, Philadelphia: WB Saunders; 2004. p. 783-823.
3. Baldacci ER, Vico ESR. Mortalidade por varicela em crianças atendidas em creche. Pediatria (São Paulo). 2002;23:213-6.
4. Yu Alf, Costa JM, Amaku M, Pannuti CS, Souza VAUF, Zanetta DMT. Three year seroepidemiological study of varicella-zoster virus in São Paulo, Brazil. Rev Inst Med Trop S. Paulo. 2000;42:125-8.
5. Centro de Vigilância Epidemiológica (CVE) "Alexandre Vranjac" Divisão de Doenças Respiratórias e Divisão de Zoonoses. Varicela, difteria e febre maculosa brasileira: aspectos epidemiológicos no Estado de São Paulo. Rev Saúde Pública. 2003;37:817-20.
6. Diez-Domingo J, Aristegui J, Calbo F, Gonzalez-Hachero J, Moraga F, Pena Guitian J, et al. Epidemiology and economic impact of varicella in immunocompetent children in Spain. A nation-wide study. Vaccine. 2003;21:3236-9.
7. Rentier B, Gershon AA, Members of EuroVar Consensus: Varicella vaccination of healthy children: a challenge for Europe. Pediatric Infect Dis J. 2004;23:379-89.
8. Law B, Macdonald N, Halperin S, Scheifele D, Déry P, Jadavji T. The Immunization Monitoring Program Active (IMPACT) prospective five year study of Canadian children hospitalized for chickenpox or an associated complication. Pediatric Infect Dis J. 2000;19:1053-9.
9. Ziebold C, Von Kries R, Lang R, Weigl J, Schmitt HJ. Severe complications of varicella in previously healthy children in Germany: a 1-year survey. Pediatrics. 2001;108:E79.
10. National Advisory Committee on Immunization (NACI) up date on varicella. Can Commun Dis Rep. 2004;1:1-26.
11. Center for Disease Control and Prevention: Prevention of varicella. Update recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR. 1999;48(RR-6):1-5.
12. Rawson H, Crampin A, Noah N. Death from chickenpox in England and Wales 1995-7: analysis of routine mortality data. BMJ. 2001;323:1091-3.
13. Carvalho ES, Martins RM. Varicela: aspectos clínicos e prevenção. J Pediatr (Rio J). 1999;75(Supl 1):126-34.
14. Nogueira AS, Pereira NG, Moreira RB, Pinho AMF. Complicações da varicela. ARS Cvrandi. 1986;19:127-8.
15. Clemens SAC, Azevedo T, Fonseca JC, Silva AMC, Silveira T, Clemens R. Soroepidemiologia da varicela no Brasil: resultados de um estudo prospectivo transversal. J Pediatr (Rio J). 1999;75:433-41.
16. Marcitelli R, Botejo LH, Bertoli CJ, Bricks LF, Oliveira AM, Marcitelli CR. Hospitalizações Infantis por varicela-zoster no Hospital Universitário de Taubaté. Annais 32° Congresso Brasileiro de Pediatria;2003;São Paulo. (Resumo)
17. Peterson Cl, Mascola L, Chao SM, Lieberman JM, Arcinue EL, Blumberg DA. Children hospitalized for varicella: a prevaccine review. J Pediatr. 1996;129:529-36.
18. Ferson MJ, Shen WL, Stark A. Direct and indirect cost of chickenpox in young children MMWR Morb Mortal Wkly Rep. 1997;46:944-8.
19. Migasena S, Simasathien S, Desakorn V, Phomrat B, Suntharasamai P, Pitisuttitham P. Seroprevalence of varicella-zoster virus antibody in Thailand. Int J Infect Dis. 1997;2:26-30.
20. Ministério da Saúde, Departamento de Informática do Sistema Único de Saúde DATASUS 1998-2000; Malha digital do Brasil: situação em 1997. Rio de Janeiro: IBGE, 1999. [citado 2002 Jun 28]. Assessed:
21. Dean AG, Dean JA, Coulombier D, Brendel KA, Smith DC, Burton AH. Epi info Version 6: a word processing database, and statistics program for epidemiology on microcomputer. Atlanta, Georgia: Center of Disease Control and Prevention; 1994.
22. Lieu TA, Cochi Sl, Black SB, Halloran ME, Shinefield HR, et al. Cost effectiveness of a routine varicella vaccination program for US children. JAMA. 1994;271:375-81.
23. USE of pulsed field gel electrophoresis for investigation of a cluster of invasive group A streptococcal illness. Spokane, Washington, 1999. MMWR Mor Mortal Wkly Rep.1999;48:681-3.
24. Saddier P, Floret D, Guess HA, Durr F, Peyrieux JC, Weber DJ, Plotkin SA. Cost of Varicella in France: a study in day care centers. J Paediatr Child Health. 1998;34:18-21.
25. Sennerstam RB. Absence due to illness among toddlers in day care centers in relation to child group structure. Public Health. 1997;111:85-8.
26. Fonseca W, Kirkwood BR, Barros AJD, Misago C, Correia LL, Flores JAM, et al . Attendance at day care centers increases the risk of childhood pneumonia among the urban poor in Fortaleza, Brazil. Cad Saúde Pública. 1996;12:133-40.
27. Vafai A, Berger N. Zoster in patients infectated with HIV: a review. Am J Med sci. 2001;321:372-80.
28. Bricks LF. Uso de antiinflamatórios não-hormonais em crianças com doenças virais vs. Risco de síndrome de Reye e doenças invasivas por S pyogenes. Pediatria. (S. Paulo). 2000; 22:35-43.
29. Walker P, Suvarna R. Is aspirin a cause of Reye's syndrome? Drug Safety. 2004; 27:71-4.
30. Davis MM, Patel MS, Gebremariam A. Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics. 2004;114:786-92.
31. Nguyen HQ, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med. 2005;352:450-8.
32. Zhou F, Harpaz R, Jumaan AO, Winston CA, Shefer A. Impact of varicella vaccination on health care utilization. JAMA. 2005;294:797-802.